Literature DB >> 28608737

Preoperative 18F-FDG-PET/CT vs Contrast-Enhanced CT to Identify Regional Nodal Metastasis among Patients with Head and Neck Squamous Cell Carcinoma.

Joshua K Cho1, Thomas J Ow2, Andrew Y Lee2, Richard V Smith2, Nicolas F Schlecht1,3, Bradley A Schiff2, Andrew B Tassler4, Juan Lin1, Renee M Moadel5, Ana Valdivia5, Tony Abraham5, Edwin Gulko5, Matthew Neimark5, Berrin Ustun5, Jacqueline A Bello5, Keivan Shifteh5.   

Abstract

Objective Our objective was to compare the accuracy of preoperative positron emission tomography (PET)/computed tomography (CT) and contrast-enhanced CT (CECT) in detecting cervical nodal metastases in patients treated with neck dissection and to scrutinize the ability of each modality to determine nodal stage. Study Design Case series with chart review. Setting Montefiore Medical Center, Bronx, New York. Subjects and Methods Patients who underwent neck dissection at our institution for primary treatment of head and neck squamous cell carcinoma (HNSCC) and had received preoperative PET/CT and CECT were included in this study. Imaging studies were reinterpreted by 3 specialists within the field and compared for interreader agreement. Concordance between radiology and histopathology was measured using neck levels and sides, along with patient nodal stage. Sensitivity, specificity, accuracy, positive predictive value, negative predictive value, and agreement coefficients were calculated. Results Seventy-three patients were included in the study. Sensitivity was 0.69 and 0.94 (level and side) for PET/CT vs 0.53 and 0.66 for CECT ( P = .056, P = .001). Specificity was 0.86 and 0.56 for PET/CT vs 0.91 and 0.76 for CECT ( P = .014, P = .024). No significant difference was found in overall accuracy ( P = .33, P = .88). The overall agreement percentages between N stage called by imaging modality and pathology were 52% and 55% for PET/CT and CECT, respectively. Conclusion No significant difference in sensitivity was found between PET/CT and CECT. CECT was found to have superior specificity compared with PET/CT. The information gleaned from each modality in the pretreatment evaluation of HNSCC appears to be complementary.

Entities:  

Keywords:  PET/CT; contrast-enhanced CT; head and neck squamous cell carcinoma; neck dissection; nodal staging; preoperative imaging

Mesh:

Substances:

Year:  2017        PMID: 28608737      PMCID: PMC6372372          DOI: 10.1177/0194599817703927

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  36 in total

Review 1.  Rationale for elective neck dissection.

Authors:  K T Pitman
Journal:  Am J Otolaryngol       Date:  2000 Jan-Feb       Impact factor: 1.808

2.  Use of integrated 18F-FDG PET/CT to improve the accuracy of initial cervical nodal evaluation in patients with head and neck squamous cell carcinoma.

Authors:  Han-Sin Jeong; Chung-Hwan Baek; Young-Ik Son; Man Ki Chung; Dong Kyung Lee; Joon Young Choi; Byung-Tae Kim; Hyung-Jin Kim
Journal:  Head Neck       Date:  2007-03       Impact factor: 3.147

3.  Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.

Authors:  Jong-Lyel Roh; Nam-Kyung Yeo; Jae Seung Kim; Jeong Hyun Lee; Kyung-Ja Cho; Seung-Ho Choi; Soon Yuhl Nam; Sang Yoon Kim
Journal:  Oral Oncol       Date:  2007-01-04       Impact factor: 5.337

Review 4.  Clinical role of 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma.

Authors:  Andrew Quon; Nancy J Fischbein; I Ross McDougall; Quynh-Thu Le; Billy W Loo; Harlan Pinto; Michael J Kaplan
Journal:  J Nucl Med       Date:  2007-01       Impact factor: 10.057

Review 5.  Management of cervical lymph nodes in patients with head and neck cancer.

Authors:  G B Snow; P Patel; C R Leemans; R Tiwari
Journal:  Eur Arch Otorhinolaryngol       Date:  1992       Impact factor: 2.503

6.  18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI.

Authors:  Heiko Schöder; Diane L Carlson; Dennis H Kraus; Hilda E Stambuk; Mithat Gönen; Yusuf E Erdi; Henry W D Yeung; Andrew G Huvos; Jatin P Shah; Steven M Larson; Richard J Wong
Journal:  J Nucl Med       Date:  2006-05       Impact factor: 10.057

Review 7.  Combined PET-CT in the head and neck: part 2. Diagnostic uses and pitfalls of oncologic imaging.

Authors:  Melanie B Fukui; Todd M Blodgett; Carl H Snyderman; Jonas J Johnson; Eugene N Myers; Dave W Townsend; Carolyn C Meltzer
Journal:  Radiographics       Date:  2005 Jul-Aug       Impact factor: 5.333

8.  An imaging-based classification for the cervical nodes designed as an adjunct to recent clinically based nodal classifications.

Authors:  P M Som; H D Curtin; A A Mancuso
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1999-04

9.  Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.

Authors:  Shu-Hang Ng; Tzu-Chen Yen; Joseph Tung-Chieh Chang; Sheng-Chieh Chan; Sheung-Fat Ko; Hung-Ming Wang; Li-Yu Lee; Chung-Jan Kang; Alex Mun-Ching Wong; Chun-Ta Liao
Journal:  J Clin Oncol       Date:  2006-09-20       Impact factor: 44.544

Review 10.  Malignant tumors of the oral cavity and oropharynx: clinical, pathologic, and radiologic evaluation.

Authors:  Alfred L Weber; Laura Romo; Sadaf Hashmi
Journal:  Neuroimaging Clin N Am       Date:  2003-08       Impact factor: 2.264

View more
  5 in total

1.  Impact of PET/CT on Staging and Treatment of Advanced Head and Neck Squamous Cell Carcinoma.

Authors:  Jeffery B Jorgensen; Russell B Smith; Andrew Coughlin; William C Spanos; Michele M Lohr; Steven M Sperry; Oleg Militsakh; Robert P Zitsch; Bevan Yueh; Laura M Dooley; Aru Panwar; Tabitha L I Galloway; Nitin A Pagedar
Journal:  Otolaryngol Head Neck Surg       Date:  2018-08-21       Impact factor: 3.497

2.  Using quantitative parameters derived from pretreatment dual-energy computed tomography to predict histopathologic features in head and neck squamous cell carcinoma.

Authors:  Hesong Shen; Yuanying Huang; Xiaoqian Yuan; Daihong Liu; Chunrong Tu; Yu Wang; Xiaoqin Li; Xiaoxia Wang; Qiuzhi Chen; Jiuquan Zhang
Journal:  Quant Imaging Med Surg       Date:  2022-02

3.  Ultrasound in patients with treated head and neck carcinomas: A retrospective analysis for effectiveness of follow-up care.

Authors:  Hongying Jiang; Qiling Tan; Fawei He; Wei Yang; Jifeng Liu; Fang Zhou; Mingxia Zhang
Journal:  Medicine (Baltimore)       Date:  2021-04-23       Impact factor: 1.817

4.  Targeting fibroblast activation protein in newly diagnosed squamous cell carcinoma of the oral cavity - initial experience and comparison to [18F]FDG PET/CT and MRI.

Authors:  Christian Linz; Roman C Brands; Olivia Kertels; Alexander Dierks; Joachim Brumberg; Elena Gerhard-Hartmann; Stefan Hartmann; Andreas Schirbel; Sebastian Serfling; Yingjun Zhi; Andreas K Buck; Alexander Kübler; Julian Hohm; Constantin Lapa; Malte Kircher
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-05-29       Impact factor: 9.236

5.  Prognostic value of 18F-FDG PET/CT parameters and histopathologic variables in head and neck cancer.

Authors:  Hale Aslan; Gul Cekin; Ercan Pinar; Mustafa Yazir; Abdulkadir Imre; Murat Songu; Akif Islek; Ibrahim Aladag; Ismail Semih Oncel
Journal:  Braz J Otorhinolaryngol       Date:  2019-12-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.